Search for: "Par Pharmaceutical"
Results 41 - 60
of 303
Sorted by Relevance
|
Sort by Date
1 Mar 2015, 9:59 pm
Par Pharmaceutical, Inc. et al. 1:15-cv-01454; filed February 25, 2015 in the District Court of Massachusetts • Plaintiff: Shire LLC • Defendants: Par Pharmaceutical, Inc.; Par Pharmaceutical Companies, Inc. [read post]
28 Dec 2014, 9:49 pm
Par Pharmaceutical Inc. 1:14-cv-01494; filed December 18 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Par Pharmaceutical Inc. [read post]
26 Oct 2007, 2:15 pm
6,593,318 & divisional 6,593,320, owned by Par Pharmaceuticals, "relate to stable flocculated suspensions of megestrol acetate and methods for making such suspensions. [read post]
12 Jul 2015, 9:59 pm
Par Sterile Products, LLC et al. 2:15-cv-03852; filed June 9, 2015 in the District Court of New Jersey • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Par Sterile Products, LLC; Par Pharmaceutical, Inc.; Par Pharmaceutical Companies, Inc. [read post]
23 Jun 2013, 8:50 pm
• Defendants: Par Pharmaceutical Inc.; Actavis Elizabeth LLC; Actavis Inc. [read post]
3 Sep 2018, 9:16 pm
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
25 Jan 2015, 9:10 pm
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
18 Jul 2012, 12:53 pm
Before reaching an agreement to sell to TPG, Par Pharmaceutical melded the two conventional approaches in negotiating its sale. [read post]
18 Jul 2012, 12:53 pm
Before reaching an agreement to sell to TPG, Par Pharmaceutical melded the two conventional approaches in negotiating its sale. [read post]
25 Nov 2014, 9:55 pm
Par Pharmaceutical, Inc. v. [read post]
12 Sep 2015, 8:01 am
Robinson in Par Pharmaceutical, Inc., et al. v. [read post]
16 Sep 2021, 12:57 pm
In its settlement with the state and counties, Endo and its subsidiaries, including Par Pharmaceutical, have been severed from the trial. [read post]
15 Jan 2015, 9:59 pm
("Par"), Roxane Laboratories, Inc. [read post]
3 Jul 2014, 9:40 pm
Par Pharmaceutical Inc. 1:14-cv-00789; filed June 20, 2014 in the District Court of Delaware Infringement of U.S. [read post]
3 Feb 2009, 2:55 pm
The Federal Trade Commission has filed a complaint in federal district court challenging agreements by Solvay Pharmaceuticals, which paid generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay launching generic versions of Solvay's brand name testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
3 Dec 2014, 9:30 am
by Dennis Crouch Par Pharma v. [read post]
4 Dec 2007, 6:33 pm
Pharmaceutical Resources and Par Pharmaceuticals v. [read post]
15 Sep 2009, 9:55 pm
Purdue originally filed suit in August 2007 in the wake of Par Pharmaceutical's filing of an Abbreviated New Drug Application (ANDA) with the FDA, claiming that Par infringed Purdue's Ultram ® patents. [read post]
16 Oct 2006, 7:58 pm
Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. [read post]
